| 发明名称 |
UNIVERSAL CANCER PEPTIDES DERIVED FROM TELOMERASE |
| 摘要 |
The invention relates to a peptide of 15 to 20 amino acids deriving from TERT protein, which peptide is capable of (i) binding to HLA class II and (ii) stimulating a CD4 Th response. These universal cancer peptides are especially useful in anti-tumor immunotherapy and immunomonitoring. |
| 申请公布号 |
US2015283219(A1) |
申请公布日期 |
2015.10.08 |
| 申请号 |
US201314385534 |
申请日期 |
2013.03.07 |
| 申请人 |
INVECTYS ;Universite De Franche-Comte ;Centre Hospitalier Regional Universitaire De Besancon |
发明人 |
Langlade Demoyen Pierre;Adotevi Olivier;Dosset Magalie |
| 分类号 |
A61K39/00;G01N33/574;C12N9/12 |
主分类号 |
A61K39/00 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
Paris FR |
